Allerion
ActiveSummary
Allerion has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €88,747 and a net result of €19,515. Equity is growing by about 17% per year across the filed financial years. Its solvency ranks better than 62% of 11,191 sector peers (NACE 68, financial year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Articles of association
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- “Artikel 17: Bevoegdheden en vertegenwoordigingsmacht Als er slechts één bestuurder is, is het geheel van de bevoegdheden van de bestuurders…”
- Board ruleHow the board is made up, meets and takes decisions.
- One provision in the deed
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Bij geen overeenstemming werkelijke waarde door partijdeskundige bij onenigheid over keuze aangesteld door Voorzitter Rechtbank van Eerste…” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Third Friday of June at 14:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Ontbinding, op elk ogenblik door besluit algemene vergadering met inachtneming WVV vormvereisten, aanwezigheidsquorum en meerderheid” (deed in Dutch)1 more provision on this in the deed
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Alle stukken uitgaande van vennootschap in vereffening vermelden dat zij in vereffening is, alle handelingen nodig of dienstig voor…” (deed in Dutch)